Immunochemical determination of cellular prion protein in plasma from healthy subjects and patients with sporadic CJD or other neurologic diseases

Transfusion
D VölkelH P Schwarz

Abstract

Creutzfeldt-Jakob disease is thought to be caused by conversion of cellular prion protein (PrP) from its soluble form (PrP(sen)) to a pathologic form (PrP(res)). The occurrence of a new variant of CJD has increased the demand for a rapid assay capable of detecting a theoretical risk of transmission of the disease by blood or plasma. A quantitative sandwich ELISA for routine screening was developed for analysis of PrP levels in plasma. The time-resolved dissociation-enhanced fluorescence technology allowed a detection limit in plasma samples of approximately 50 pg/mL. Levels of PrP(sen) were tested in plasma from 31 patients with CJD, from 11 patients with other neurodegenerative diseases, and from a control group of 200 healthy subjects. The assay recognized both PrP(sen) and pathologic PrP(res), but did not differentiate between the two isoforms. PrP(sen) levels were higher in plasma from both patient groups than in plasma from the control group: 27 of the 31 (87%) CJD patients and all patients with other neurodegenerative diseases had higher levels than the highest concentration found in the control group. No correlation was found between age and PrP level. No signal could be detected in the CJD samples after protease K diges...Continue Reading

References

Oct 15, 1992·Clinica Chimica Acta; International Journal of Clinical Chemistry·T JimiK Kato
Dec 1, 1987·Journal of Virology·R J KascsakH Diringer
May 20, 1967·Nature·T AlperM C Clarke
Sep 2, 1967·Nature·J S Griffith
May 1, 1983·Acta Oto-laryngologica·L S Manolidis, S J Balojannis
Mar 1, 1984·Analytical Biochemistry·I HemmiläT Lövgren
Jul 28, 1994·Nature·J CollingeJ G Jefferys
Oct 23, 1997·Nature·A F HillP Lantos
Dec 31, 1997·Nature·P Brown
Feb 19, 1999·BMJ : British Medical Journal·F M ChapmanN R Telfer
Apr 3, 1999·Transfusion clinique et biologique : journal de la Société française de transfusion sanguine·S BrandnerA Aguzzi
Apr 30, 1999·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·J P Brandel
May 11, 1999·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·C Freitas, R H Müller
Nov 5, 1999·The Biochemical Journal·D R BrownI M Jones
Dec 22, 1999·British Journal of Haematology·G R BarclayM L Turner
Dec 28, 1999·Proceedings of the National Academy of Sciences of the United States of America·M R ScottS B Prusiner
Jan 7, 2000·Biochemical and Biophysical Research Communications·N ShiraishiM Nishikimi

❮ Previous
Next ❯

Citations

Jan 19, 2013·Biochimie·Giuseppe Scalabrino, Daniela Veber
Feb 13, 2003·Pediatric Clinics of North America·Keith C Quirolo
Jun 18, 2002·Trends in Molecular Medicine·Loredana IngrossoMaurizio Pocchiari
Nov 20, 2002·British Journal of Haematology·Richard StarkePaul Harrison
Apr 16, 2002·Haemophilia : the Official Journal of the World Federation of Hemophilia·L CervenakovaE L Saenko
Apr 24, 2001·Transfusion·P Brown
Nov 29, 2001·Transfusion·I MacGregor, O Drummond
Oct 18, 2001·Current Opinion in Hematology·M L Turner
Mar 6, 2003·Vox Sanguinis·C V Prowse, I R MacGregor
Jun 19, 2008·Annual Review of Neuroscience·Adriano AguzziJuliane Bremer
Sep 23, 2006·BMC Neurology·Constanze Boesenberg-GrosseInga Zerr
Jul 3, 2007·Proceedings of the National Academy of Sciences of the United States of America·Anthony L LauDavid Peretz
Sep 13, 2012·Experimental Gerontology·Lutz Philipp BreitlingHermann Brenner
May 9, 2009·Experimental Neurology·W A BanksC Soto
Jun 13, 2006·Transfusion Medicine·R StarkeS Machin
Sep 14, 2006·Clinical and Experimental Immunology·J D IsaacsD M Altmann
Aug 24, 2013·Clinical & Developmental Immunology·Anja LukanVladka Curin Šerbec
Jul 15, 2015·Biochemical and Biophysical Research Communications·Yeon-Jae SeongEui-Cheol Shin
May 13, 2004·Expert Review of Molecular Diagnostics·Bart Van EverbroeckPatrick Cras
May 13, 2009·Laboratory Investigation; a Journal of Technical Methods and Pathology·Ed M ChoiStanley B Prusiner
Nov 22, 2011·Muscle & Nerve·Giuseppe ScalabrinoGiovanni Tredici
Nov 3, 2006·Clinical and Vaccine Immunology : CVI·Binggong ChangMan-Sun Sy

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bovine Spongiform Encephalopathy (MDS)

Bovine spongiform encephalopathy is a neurodegenerative disease belonging to the transmissible spongiform encephalopathies, a group of diseases including sheep scrapie and human Creutzfeldt-Jakob disease. Here is the latest research.

Bovine Spongiform Encephalopathy

Bovine spongiform encephalopathy is a neurodegenerative disease belonging to the transmissible spongiform encephalopathies, a group of diseases including sheep scrapie and human Creutzfeldt-Jakob disease. Here is the latest research.